Evo 0.5% is a broad-spectrum, third-generation fluoroquinolone antibiotic belonging to the therapeutic class of 4-Quinolone preparations. It is designed for the effective management of a wide range of bacterial infections in adults. Evo 0.5% demonstrates potent antibacterial activity against both Gram-positive and Gram-negative organisms, making it a reliable option for treating mild to severe infections across multiple body systems.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Evo 0.5% is indicated for the treatment of the following infections in adults (18 years of age and above):

• Respiratory tract infections, including:

  • Acute bacterial sinusitis

  • Acute exacerbation of chronic bronchitis

  • Community-acquired pneumonia

  • Nosocomial (hospital-acquired) pneumonia

• Uncomplicated and complicated skin and soft tissue infections

• Chronic bacterial prostatitis

• Uncomplicated and complicated urinary tract infections (mild to moderate)

Pharmacology

Evo 0.5% is a synthetic, chiral fluorinated carboxyquinolone antibiotic. It exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, repair, and recombination. This dual enzyme inhibition prevents bacterial cell division and leads to rapid bacterial cell death. Evo 0.5% shows strong in-vitro activity against a wide range of Gram-positive and Gram-negative pathogens.

Dosage and Administration

The dosage of Evo 0.5% depends on the type and severity of infection:

• Acute sinusitis: 500 mg once daily for 10–14 days

• Acute exacerbation of chronic bronchitis: 250–500 mg once daily for 7–10 days

• Community-acquired pneumonia: 500 mg once or twice daily for 7–14 days

• Nosocomial pneumonia: 750 mg once daily for 7–14 days

• Skin and soft tissue infections: 500 mg once or twice daily for 7–14 days

• Chronic bacterial prostatitis: 500 mg once daily for 28 days

• Urinary tract infections:

  • 250 mg once daily for 7–10 days

  • 250 mg once daily for 3 days in uncomplicated infections

Dose adjustment is required in patients with impaired renal function.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

• Antacids, iron preparations, and adsorbents may reduce the absorption of Evo 0.5%

• Concomitant use with NSAIDs may increase the risk of central nervous system stimulation

• Warfarin may increase the risk of bleeding when used alongside Evo 0.5%

Contraindications

Evo 0.5% is contraindicated in patients with known hypersensitivity to fluoroquinolone antibiotics or any component of this formulation.

Side Effects

Evo 0.5% is generally well tolerated. Commonly reported side effects include:

• Nausea

• Vomiting

• Diarrhea

• Abdominal pain

• Flatulence

Rarely, phototoxic reactions may occur. Very rare adverse effects include tremors, anxiety, depression, confusion, and other central nervous system disturbances.

Pregnancy and Lactation

Evo 0.5% is classified as US FDA pregnancy category C. Its use during pregnancy and lactation should be avoided unless the potential benefits clearly outweigh the possible risks to the fetus or infant.

Precautions and Warnings

• Adequate fluid intake should be maintained during therapy to prevent urine concentration

• Caution is advised in patients with renal impairment

• Prolonged or inappropriate use may increase the risk of adverse effects

Storage Conditions

Store in a dry place away from light and heat. Keep out of the reach of children.